Automated 3D MRI Decision Tree to guide referral and diagnosis of parkinsonian disorders
Lists
Only you see this
Abstract
For screening and diagnosis of Parkinson disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy-parkinsonian/cerebellar subtypes (MSA-P/MSA-C), we propose a two-step decision tree using a novel MRI biomarker and volumetric measures. MRIs from 50 MSA-C, 22 MSA-P, 50 PSP, 50 PD, and 172 age/legal-sex-matched control were used for fully automated volumetric analysis of the brain and brainstem. Sensitivity/specificity for diseased vs control was 90.1/90.7%. Then, a comprehensive tree with the diseased group yielded sensitivity/specificity of 81.9/93.0% (MSA), 94.0/88.5% (MSA-C), 54.5/96.0% (MSA-P), 74.0/86.0% (PD), 76.0/98.4% (PSP). We provide a reproducible and specific diagnostic tool for screening and initial differential diagnosis.
BibTeX
@inproceedings{kim2023automated,
author = {Ji‐Soo Kim and Andrew Willett and Grace F. Crotty and Merlyne Mesidor and Camden Bay and Xiaoyin Xu and Lei Qin and Vikram Khurana and Geoffrey S. Young},
title = {{Automated 3D MRI Decision Tree to guide referral and diagnosis of parkinsonian disorders}},
booktitle = {Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition},
year = {2023},
doi = {10.58530/2022/2273},
}Loading related content...